D2 lymphadenectomy in gastric cancer surgery-Reference-Cited by-同舟云学术

D2 lymphadenectomy in gastric cancer surgery

Published:2009-06 Issue:3 Volume:6 Page:162-168
ISSN:1674-5361
Container-title:Clinical Oncology and Cancer Research
language:en
Short-container-title:Clin. Oncol. Cancer Res.

Author:

Deng Jingyu,Liang Han

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11805-009-0162-3.pdf

Reference91 articles.

1. Parkin DM. International variation. Oncogene 2004; 23: 6329–6340.

2. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: cancer incidence. Mortality and prevalence worldwide. IARC cancer base no. 5, version 2.0, Lyon (France): 2004 IARC Press.

3. Dahlberg M, Glimelius B, Påhlman L. Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the results of Swedish Rectal Cancer Trial. Ann Surg 1999; 229: 493–497.

4. Sano T, Sasako M, Yamamoto S, et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group study 9501. J Clin Oncol 2004; 22: 2767–2773.

5. Kulig J, Popiela T, Kolodziejczyk P, et al. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg 2007; 193: 10–15.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Superiority of the Ratio Between Negative and Positive Lymph Nodes for Predicting the Prognosis for Patients With Gastric Cancer;Annals of Surgical Oncology;2014-10-16